Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
May 19, 2017
Clinical News
Jazz's Xyrem meets in Phase II/III for pediatric narcolepsy with cataplexy
Read More
BioCentury
|
Jan 12, 2015
Clinical News
Xyrem sodium oxybate: Phase III started
Read More
BioCentury
|
Dec 24, 2012
Clinical News
Xyrem sodium oxybate regulatory update
Read More
BioCentury
|
May 7, 2012
Strategy
Jazz's big band sound
Jazz continues specialty acquisition strategy, but will shift focus to R&D buys
Read More
BioCentury
|
Oct 24, 2011
Clinical News
Xyrem sodium oxybate regulatory update
Read More
BioCentury
|
May 9, 2011
Finance
Highlights of weekly biotech stock moves
Regulatory, clinical and other milestones
Read More
BioCentury
|
May 9, 2011
Clinical News
Sodium oxybate: Development discontinued
Read More
BioCentury
|
May 4, 2011
Company News
Jazz drops fibromyalgia plans
Read More
BioCentury
|
Mar 21, 2011
Clinical News
Xyrem sodium oxybate regulatory update
Read More
BioCentury
|
Feb 7, 2011
Clinical News
Xyrem sodium oxybate regulatory update
Read More
Items per page:
10
1 - 10 of 61